Lannett Investors Seek Final OK Of $5.8M Price-Fix Probe Suit
Former executives of pharmaceutical company Lannett Inc. and a class of investors have asked a Pennsylvania federal court to grant final approval to their $5.8 million deal to end claims the...To view the full article, register now.
Already a subscriber? Click here to view full article